Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VYGR | AZN | AMGN | GILD | GSK |
| Company | Voyager Therapeut | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.41 | 212.66 | 373.50 | 156.01 | 61.54 |
| High | 3.49 | 212.71 | 379.81 | 156.01 | 61.70 |
| Low | 3.38 | 207.52 | 370.44 | 152.62 | 60.99 |
| Latest | 3.40 | 208.02 | 378.20 | 152.88 | 61.17 |
| Change | -0.01 | -1.46 | +4.84 | -2.39 | +0.30 |
| % Change | -0.29% | -0.70% | +1.30% | -1.54% | +0.49% |
| Volume | 203,603 | 1,883,547 | 1,147,529 | 2,304,543 | 3,803,726 |
| 20-Day Average Volume | 582,554 | 3,065,881 | 3,030,959 | 8,340,607 | 6,599,857 |
| Previous Close | 3.41 | 209.48 | 373.36 | 155.27 | 60.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.76 | 192.07 | 357.95 | 145.00 | 54.88 |
| 20-Day Raw Stochastic | 13.19% | 86.63% | 87.44% | 87.14% | 95.55% |
| 20-Day Relative Strength | 38.21 | 66.16 | 64.73 | 65.96 | 75.98 |
| Weighted Alpha | -27.22 | +50.04 | +34.02 | +49.97 | +80.25 |
| Today's Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 64% Buy | 72% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.30% since 02/10/26 | +7.59% since 02/10/26 | +3.69% since 02/10/26 | +3.81% since 02/10/26 | +3.83% since 02/10/26 |
| Low | 3.31 on 02/17/26 | 199.19 on 02/11/26 | 361.00 on 02/11/26 | 147.38 on 02/11/26 | 58.01 on 02/11/26 |
| High | 3.78 on 02/11/26 | 212.71 on 02/18/26 | 379.81 on 02/18/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | -8.78% since 01/16/26 | +10.22% since 01/16/26 | +14.44% since 01/16/26 | +22.36% since 01/16/26 | +26.65% since 01/16/26 |
| Low | 3.31 on 02/17/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 47.62 on 01/20/26 |
| High | 4.22 on 01/22/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | -19.86% since 11/18/25 | +16.18% since 11/18/25 | +9.92% since 11/18/25 | +20.18% since 11/18/25 | +28.92% since 11/18/25 |
| Low | 3.31 on 02/17/26 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.81 on 11/20/25 |
| High | 4.58 on 12/16/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -10.68% since 08/18/25 | +31.50% since 08/18/25 | +29.22% since 08/18/25 | +29.54% since 08/18/25 | +56.31% since 08/18/25 |
| Low | 3.28 on 08/21/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 5.55 on 10/16/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 189,596 | 324,884,192 | 201,047,264 | 192,640,400 | 124,077,768 |
| Shares Outstanding, K | 55,600 | 1,550,908 | 538,481 | 1,240,680 | 2,038,406 |
| Annual Sales | 80,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -65,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 13,370,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -27,890,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 1.30 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 11/10/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 03/10/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.426 on 11/14/25 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.38 | 16.90 | 19.02 | 13.04 |